Scarica l'app Stockscreener
2.985
1.19%
0.035
Pre-mercato:
2.96
-0.025
-0.84%
Incannex Healthcare Inc Borsa (IXHL) Ultime notizie
Incannex Healthcare Inc. (IXHL) Stock Price | Live Quotes & Charts | NASDAQ - timothysykes.com
TradingKey - TradingKey
IXHL|Incannex Healthcare Inc|Price:2.985|Chg%:+0.035 - TradingKey
Incannex Healthcare Inc (IXHL) Institutional Confidence - TradingKey
Why Did IXHL Stock Tank Over 32% Today? - Stocktwits
Incannex Healthcare Inc (IXHL) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Incannex Healthcare Inc. (IXHL) Stock Price, News, Quote & History - Yahoo! Finance Canada
Incannex Healthcare Inc (IXHL) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Incannex Healthcare Inc (IXHL) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Incannex Healthcare Inc. (IXHL) stock price, news, quote and history - Yahoo Finance Singapore
Incannex Healthcare Inc. Commences Participant Screening In Dreamzz Phase 2 Study Of IHL-42X For Obstructive Sleep Apnea - marketscreener.com
Incannex starts screening for Phase 2 study of IHL-42X to treat obstructive sleep apnea with FDA Fast Track status - Pluang
Incannex Commences Participant Screening in DReAMzz Phase 2 Study of IHL-42X for Obstructive Sleep Apnea - The Manila Times
Incannex Commences Screening in Phase 2 DReAMzz Study of IHL-42X for OSA - TradingView
Incannex starts screening patients in Phase 2 DReAMzz trial of IHL-42X for sleep apnea - Bitget
IXHL Stock Rips To Best Day In 5 Months: Nasdaq Compliance Back In Sight As FDA Catalyst For Sleep Apnea Drug Looms - Stocktwits
What Has Incannex (ASX:IHL) in Health Debate? - Kalkine Media
Incannex Secures US Patent for Sleep Apnea Drug Candidate IHL-42X - Sleep Review
Incannex (IXHL) Secures U.S. Patent Grant in Obstructive Sleep Apnea for IHL-42X - Yahoo Finance
Incannex Healthcare Q2 2026 Earnings: Large EPS Miss but Stock Gains as Investors Focus on Pipeline ProgressBalance Sheet Strength - dars.gov.et
IXHL Q2 2026 Earnings: Significant EPS Miss as Pre-Revenue Biotech Ramps Up R&D SpendingCash Flow Report - dars.gov.et
Incannex Healthcare(IXHL) Stock Options Chain | Quotes & News - Moomoo
Incannex Healthcare (ASX:IHL): Why Is This Cannabis Innovator Back in Focus? - Kalkine Media
Price to earnings forward of Incannex Healthcare Inc. – NASDAQ:IXHL - TradingView
Price to book forward of Incannex Healthcare Inc. – NASDAQ:IXHL - TradingView
IXHL Q2 2026 Earnings: Significant EPS Miss Amid No Revenue, Yet Stock SurgesEarnings Yield Spread - dars.gov.et
Enterprise value to EBIT forward of Incannex Healthcare Inc. – NASDAQ:IXHL - TradingView
Price to sales forward of Incannex Healthcare Inc. – NASDAQ:IXHL - TradingView
Tranche Update on Incannex Healthcare Inc.'s Equity Buyback Plan announced on August 22, 2025. - marketscreener.com
Sleep Apnea Market Expected to Experience Accelerated Growth and Market Evolution by 2034 – DelveInsight | Apnimed, Eli Lilly, Incannex Healthcare, Axsome Therapeutics, Jazz Pharma, Bioprojet - Barchart.com
Incannex Healthcare (IXHL) Stock Forecast & Analyst Ratings - Moomoo
IXHL Forecast — Price Target — Prediction for 2027 - TradingView
Neuropsychiatric medicine reaches an inflexion point: regulation, science and the road to commercial reality - Manufacturing Chemist
Incannex Healthcare Inc. Actuals & Estimates (NASDAQ:IXHL) - TradingView
Incannex Healthcare Inc (IXHL) Valuation: PE, PB & Fair Value Analysis - TradingKey
A2DF4D Forecast — Price Target — Prediction for 2027 - TradingView
Incannex receives U.S. patent for sleep apnea drug IHL-42X By Investing.com - Investing.com South Africa
Incannex receives U.S. patent for sleep apnea drug IHL-42X - Investing.com
Incannex Healthcare Receives US Patent for IHL-42X in Obstructive Sleep Apnea - marketscreener.com
Incannex Secures U.S. Patent Grant for IHL-42X in Obstructive Sleep Apnea - The Manila Times
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Incannex's sleep apnea drug gets U.S. patent protection to 2040 - Stock Titan
Incannex (IXHL) secures long-dated U.S. patent for IHL-42X sleep apnoea therapy - Stock Titan
Incannex Healthcare Inc (IXHL) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Incannex Healthcare Inc (IXHL) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Why Is Incannex (ASX:IHL) Emerging as a Clinical Cannabis Story? - Kalkine Media
Incannex Healthcare Inc (IXHL) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Incannex Healthcare (IXHL) Proxy Filing Summary - Quartr
0.30%
2.01%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):